Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angioplasty, Transluminal, Percutaneous Coronary”

132 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 132 results

Not applicableStudy completedNCT00942500
What this trial is testing

Effects of Postconditioning On Myocardial Reperfusion

Who this might be right for
Myocardial ReperfusionMyocardial Infarction
Samsung Medical Center 700
Not applicableStudy completedNCT00005677
What this trial is testing

Percutaneous Transluminal Coronary Angioplasty (PTCA) Registries I, II, and III and the Dynamic Registry

Who this might be right for
Cardiovascular DiseasesCoronary DiseaseHeart Diseases
University of Pittsburgh 4,290
Post-approval studies (Phase 4)Study completedNCT01200693
What this trial is testing

Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

Who this might be right for
Coronary Artery DiseaseCoronary Stenosis
Catholic University of the Sacred Heart 80
Not applicableLooking for participantsNCT07425171
What this trial is testing

Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion

Who this might be right for
PTA (Percutaneous Transluminal Angioplasty)Femoropopliteal Artery DiseaseLong Femoropopliteal Artery Disease
Genoss Co., Ltd. 300
Not applicableEnrolling By InvitationNCT07399080
What this trial is testing

Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease

Who this might be right for
PTA (Percutaneous Transluminal Angioplasty )Femoropopliteal Artery Disease
Genoss Co., Ltd. 200
Not applicableStudy completedNCT02047942
What this trial is testing

Telerehabilitation in Coronary Heart Disease

Who this might be right for
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))Myocardial InfarctionPercutaneous Transluminal Cutting Balloon Angioplasty of Popliteal Vein Using Fluoroscopic Guidance
KU Leuven 90
Post-approval studies (Phase 4)Study completedNCT00611169
What this trial is testing

The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Samsung Medical Center 40
Not applicableLooking for participantsNCT05972070
What this trial is testing

Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence

Who this might be right for
Myocardial InfarctionPercutaneous Transluminal Coronary AngioplastyCoronary Artery Bypass+5 more
ROM Technologies, INC 500
Testing effectiveness (Phase 2)Study completedNCT00771004
What this trial is testing

Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.

Who this might be right for
Oxidative StressCoronary Artery DiseaseType 2 Diabetes
Takeda 63
Post-approval studies (Phase 4)Study completedNCT00987610
What this trial is testing

Guidewire for Chronic Total Occlusion

Who this might be right for
Coronary Occlusion
Tokai University 260
Post-approval studies (Phase 4)Study completedNCT00349895
What this trial is testing

Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth

Who this might be right for
Coronary Artery DiseaseCoronary Artery Stenosis
OrbusNeich 100
Not applicableStudy completedNCT01883050
What this trial is testing

Application for Self-Monitoring of Cardiovascular Risk

Who this might be right for
Coronary Disease
Mayo Clinic 80
Large-scale testing (Phase 3)Ended earlyNCT00557921
What this trial is testing

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Cogentus Pharmaceuticals 5,000
Post-approval studies (Phase 4)Ended earlyNCT02831205
What this trial is testing

Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease

Who this might be right for
Percutaneous Transluminal Coronary Angioplasty
Duk-Woo Park, MD 800
Not applicableStudy completedNCT00794014
What this trial is testing

Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion

Who this might be right for
Coronary Artery Disease
Samsung Medical Center 258
Post-approval studies (Phase 4)UnknownNCT00870038
What this trial is testing

To Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study

Who this might be right for
Angioplasty, Transluminal, Percutaneous CoronaryPercutaneous Coronary Intervention
Ospedale della Misericordia 75
Post-approval studies (Phase 4)UnknownNCT00938522
What this trial is testing

Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention

Who this might be right for
Angioplasty, Transluminal, Percutaneous Coronary
Samsung Medical Center 400
Post-approval studies (Phase 4)Ended earlyNCT01068119
What this trial is testing

Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)

Who this might be right for
Acute Coronary Syndrome
Piedmont Healthcare 57
Large-scale testing (Phase 3)UnknownNCT00637104
What this trial is testing

European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent

Who this might be right for
Coronary Artery DiseaseAngioplasty, Transluminal, Percutaneous CoronaryStents
International Biomedical Systems S.p.A. 160
Testing effectiveness (Phase 2)Study completedNCT01442792
What this trial is testing

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention

Who this might be right for
Cardiovascular DiseaseCoronary Artery Disease
Bayer 108
Next Page